|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
KNOVEL_on1147841549 |
| 003 |
OCoLC |
| 005 |
20231027140348.0 |
| 006 |
m o d | |
| 007 |
cr ||||||||||| |
| 008 |
191212s2020 ne go 000 0 eng d |
| 040 |
|
|
|a UKAHL
|b eng
|e rda
|e pn
|c UKAHL
|d UKMGB
|d OCLCO
|d OCLCQ
|d OCLCF
|d EBLCP
|d UK7LJ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBC013076
|2 bnb
|
| 016 |
7 |
|
|a 019690402
|2 Uk
|
| 020 |
|
|
|a 9780128184721
|z 9780128184714
|q (e-book)
|
| 020 |
|
|
|a 0128184728
|
| 029 |
1 |
|
|a UKMGB
|b 019690402
|
| 035 |
|
|
|a (OCoLC)1147841549
|
| 037 |
|
|
|a 9780128184721
|b Ingram Content Group
|
| 050 |
|
4 |
|a T174.7
|
| 082 |
0 |
4 |
|a 615.6
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering /
|c edited by Lisa du Toit, Pradeep Kumar, Yahya Choonara, Viness Pillay.
|
| 264 |
|
1 |
|a Amsterdam :
|b Elsevier,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Woodhead Publishing series in biomaterials
|
| 505 |
0 |
|
|a Front Cover -- Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering -- Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering -- Copyright -- Contents -- Contributors -- Preface -- 1 -- Bioinks for 3D printing of artificial extracellular matrices -- 1. Introduction -- 2. Printing technologies used in three-dimensional printing -- 2.1 Inkjet printing -- 2.2 Orifice-free bioprinting -- 2.3 Extrusion bioprinting -- 3. Application of 3D printing -- 3.1 Medical applications -- 3.1.1 Bioprinting technology -- 3.2 Anatomical models
|
| 505 |
8 |
|
|a 3.3 3D printed dosage form -- 4. Regulatory aspects -- 5. Bioinks -- 5.1 Scaffold-based bioink materials -- 5.1.1 Hydrogels -- 5.1.1.1 Bioprintability of hydrogels -- 5.1.1.2 Cross-linking mechanisms of hydrogels -- 5.1.1.2.1 Physical cross-linking -- 5.1.1.2.2 Chemical cross-linking -- 5.1.1.2.3 Enzyme-assisted cross-linking -- 5.1.2 Microcarriers -- 5.1.3 Decellularized cell matrices -- 5.2 Scaffold-free bioink materials -- 5.2.1 Tissue spheroids -- 5.2.2 Tissue strands -- 5.2.3 Cell pellet -- 6. Novel material for bioink -- 6.1 Laponite -- 6.2 Silk-based scaffold
|
| 505 |
8 |
|
|a 6.3 Nanotechnology-based bioink -- 6.4 Pectin-based bioink -- 7. Artificial extracellular matrix -- 7.1 Classification -- 7.2 Artificial ECM for skin -- 7.3 Artificial ECM for cartilage -- 7.4 Artificial ECM for vascular -- 7.5 Artificial ECM for cardiac valve -- 8. Conclusion -- References -- 2 -- Applications of 3D printing for the advancement of oral dosage forms -- 1. Introduction -- 2. History -- 3. Three-dimensional printing techniques -- 4. Three-dimensional printing in oral dosage form design and fabrication -- 5. Existing 3D-printed solid oral dosage forms
|
| 505 |
8 |
|
|a 6. Advantages of 3D printing over conventional solid oral dosage forms -- 7. Applications of 3D printing -- 8. Limitations -- 9. The current context of 3D printing over conventional dosage form techniques -- 10. Major challenges of 3D printing -- 11. Recent trends in the FDA regulation -- 12. Conclusion -- References -- 3 -- Recent progress in 3D-printed polymeric scaffolds for bone tissue engineering -- 1. Introduction -- 2. Conventional 3D printing methodologies employed in bone tissue-engineered platforms -- 2.1 Selective laser sintering -- 2.2 Stereolithography -- 2.3 Fused deposition modeling
|
| 505 |
8 |
|
|a 3. Three-dimensional bioprinting employed for bone tissue engineering -- 3.1 Inkjet-based bioprinting -- 3.2 Extrusion-based bioprinting -- 3.3 Laser-assisted bioprinting -- 4. Progress in 3D-printed natural and synthetic polymeric scaffolds for bone tissue engineering -- 4.1 Natural 3D-printed scaffolds for bone tissue engineering -- 4.2 Synthetic 3D-bioprinted scaffolds -- 4.3 Natural polymer-based composite scaffolds -- 4.4 Synthetic polymer-based composite scaffolds -- 5. Concluding remarks and future considerations -- Acknowledgments -- References
|
| 505 |
8 |
|
|a 4 -- Inorganic additives to augment the mechanical properties of 3D-printed systems
|
| 590 |
|
|
|a Knovel
|b ACADEMIC - Manufacturing Engineering
|
| 650 |
|
0 |
|a Drug delivery systems.
|
| 650 |
|
0 |
|a Tissue engineering.
|
| 650 |
|
0 |
|a Three-dimensional printing.
|
| 650 |
|
0 |
|a Nanostructures.
|
| 650 |
|
2 |
|a Drug Delivery Systems
|
| 650 |
|
2 |
|a Tissue Engineering
|
| 650 |
|
2 |
|a Printing, Three-Dimensional
|
| 650 |
|
2 |
|a Nanostructures
|
| 650 |
|
6 |
|a Systèmes d'administration de médicaments.
|
| 650 |
|
6 |
|a Génie tissulaire.
|
| 650 |
|
6 |
|a Impression tridimensionnelle.
|
| 650 |
|
6 |
|a Nanostructures.
|
| 650 |
|
7 |
|a 3-D printing.
|2 aat
|
| 650 |
|
7 |
|a Drug delivery systems
|2 fast
|
| 650 |
|
7 |
|a Nanostructures
|2 fast
|
| 650 |
|
7 |
|a Three-dimensional printing
|2 fast
|
| 650 |
|
7 |
|a Tissue engineering
|2 fast
|
| 700 |
1 |
|
|a Du Toit, Lisa,
|e editor.
|
| 700 |
1 |
|
|a Kumar, Pradeep,
|e editor.
|
| 700 |
1 |
|
|a Choonara, Yahya,
|e editor.
|
| 700 |
1 |
|
|a Pillay, Viness,
|e editor.
|
| 776 |
0 |
8 |
|i Print version :
|z 9780128184714
|
| 856 |
4 |
0 |
|u https://appknovel.uam.elogim.com/kn/resources/kpADPSNDDA/toc
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6317634
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH35307878
|
| 994 |
|
|
|a 92
|b IZTAP
|
